COMMUNIQUÉS West-GlobeNewswire

-
Progenics Pharmaceuticals Mails Letter to Shareholders
03/06/2019 -
Neon Therapeutics to Present at Jefferies 2019 Healthcare Conference
03/06/2019 -
Immutep Presentation at ASCO 2019
03/06/2019 -
Humanigen to Present at the Jefferies 2019 Healthcare Conference
03/06/2019 -
AIT Therapeutics to Participate at Jefferies 2019 Global Healthcare Conference
03/06/2019 -
Outlook Therapeutics Signs Manufacturing Supply Agreement with FUJIFILM Diosynth Biotechnologies as Part of Commercialization Strategy for ONS-5010
03/06/2019 -
Todos Medical Announces Positive Clinical Trial Data for Breast Cancer Blood Test TM-B1 in Dense Breasts
03/06/2019 -
BioSig Technologies Receives $4.6 Million in Cash Warrant and Option Exercises
03/06/2019 -
Annual General Meeting Results and Statement
03/06/2019 -
Emergent BioSolutions Awarded 10-Year HHS Contract Valued at Approximately $535 Million to Deliver Vaccinia Immune Globulin Intravenous (VIGIV) in Support of Smallpox Preparedness
03/06/2019 -
LHC Group announces finalization of purchase agreement and joint venture partnership in New Jersey
03/06/2019 -
RadNet, Inc. to Present at the Jefferies 2019 Healthcare Conference on June 7, 2019
03/06/2019 -
US FDA Review for SCENESSE® Extended by Three Months
03/06/2019 -
Arrayit Corporation Signs In-Network Allergy Testing Services Agreement with a Major California-Based Health Benefits Company
03/06/2019 -
Biohit Plc - Managers' transactions - Söderström
03/06/2019 -
Icosagen and AbCheck Announce Five-year Licensing Agreement Granting AbCheck Access to Icosagen’s Patented Mammalian Expression Technology
03/06/2019 -
Oncology Venture receives response from the FDA to the IND-application and proposed pivotal study for LiPlaCis
03/06/2019 -
New cigarette filters block up to 60% of harmful substances thanks to Bio-on biopolymers
03/06/2019 -
Grâce aux bio-polymères créés par Bio-on, les filtres de cigarettes sont en mesure de bloquer jusqu’à 60% des substances nocives
03/06/2019
Pages